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The role of NFκB in spheroid 
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Human MCF-7 breast cancer cells were exposed to a Random Positioning Machine (RPM). After 24 hours 
(h) the cells grew either adherently within a monolayer (AD) or within multicellular spheroids (MCS). AD 
and MCS populations were separately harvested, their cellular differences were determined performing 
qPCR on genes, which were differently expressed in AD and MCS cells. Gene array technology was 
applied to detect RPM-sensitive genes in MCF-7 cells after 24 h. Furthermore, the capability to form 
multicellular spheroids in vitro was compared with the intracellular distribution of NF-kappaB (NFκB) 
p65. NFκB was equally distributed in static control cells, but predominantly localized in the cytoplasm 
in AD cells and nucleus in MCS cells exposed to the RPM. Gene array analyses revealed a more than 
2-fold change of only 23 genes including some whose products are affected by oxygen levels or regulate 
glycolysis. Significant upregulations of the mRNAs of enzymes degrading heme, of ANXA1, ANXA2, 
CTGF, CAV2 and ICAM1, as well as of FAS, Casp8, BAX, p53, CYC1 and PARP1 were observed in MCS cells 
as compared with 1g-control and AD cells. An interaction analysis of 47 investigated genes suggested 
that HMOX-1 and NFκB variants are activated, when multicellular spheroids are formed.
Exposing cells to devices like the Random Positioning Machine (RPM) triggers them to change their growth 
behavior together with a number of cellular characteristics1,2. This phenomenon has been observed for several 
types of human cells including thyroid cells, chondrocytes, endothelial cells, human breast cancer MDA-MB-231 
cells and others3–9. We recently demonstrated that also human Michigan Cancer Foundation-7 (MCF-7) breast 
cancer cells form three-dimensional (3D) aggregates. Incubated on a RPM, a part of the cells switches from a 
two-dimensional (2D) growth within a monolayer to a 3D growth within multicellular spheroids (MCS), the 
other one remains adherent and continues growing within a monolayer (AD)10. The occurrence of MCS begins 
within 24 h on the RPM10. After a five-day RPM-exposure, spheroids were floating in the culture supernatant. 
At that time, the cells of the MCS have changed their gene expression pattern. Among other mRNAs, vascular 
endothelial growth factor-A (VEGFA), vascular endothelial growth factor receptor 2 (FLK1), caspase-9 (Casp9), 
caspase-3 (Casp3), and protein kinase C alpha (PRKCA) mRNAs were downregulated in five-day MCS-samples 
indicating their involvement in 3D aggregation.
Isochronally with 3D aggregation, microgravity-induced apoptosis was detected in breast cancer cells6 like 
it has been observed in other types of cells11–13. In addition, FTC-133 thyroid cancer cells exposed to the RPM 
for 24 h formed spheroids and exhibited simultaneously enhanced levels of apoptosis and of NFκB proteins as 
compared with 1g-control cells14. NFκB incorporates a variety of transcriptional regulatory functions and is 
known to be of great importance in apoptosis15. It is inactivated by binding to IκB (inhibitor of NFκB). However, 
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degradation of IκB can result in a translocation of NFκB into the nucleus, where it can activate the transcription 
of anti-apoptotic genes16. In a recent deep proteome analysis the translocation inhibitor IκBKB showed up in 
AD cells after culturing FTC-133 cells on the RPM, but could not be detected in MCS cells of the same culture 
flask17,18. These observations created the idea that a link between spheroid formation, initiation of apoptosis and 
NFκB expression may exist14. In addition, Becker-Weimann et al. postulated a link between NFκB expression and 
3D organization of human breast cancer cells19.
Therefore, the principal aim of this paper was to investigate the early phases of RPM-exposure (24 h) of 
MCF-7 breast cancer cells and to test whether there is a link between enhancement of apoptosis, changes in 
NFκB expression and spheroid formation. In a first approach, we exposed MCF-7 breast cancer cells for 24 h to 
the RPM. Afterwards, we analyzed the intracellular distribution and expression of NFκB by means of gene array 
analyses as well as quantitative (q)PCR focusing on genes involved in apoptosis and cell adhesion signaling and 
known to play a role in spheroid formation of human thyroid cells14. Furthermore, morphological and molecular 
biological results were compared. These experiments should increase the knowledge about mechanisms of the 
self-reliant formation of tissue-comparable cell-aggregates. Finding molecules in various cell types, which medi-
ate a microgravity-dependent cell organization in equal ways, may indicate new targets to improve tissue engi-
neering and cancer treatment. In a further step, we investigated the impact of the poly ADP ribose polymerase 
(PARP) inhibitor olaparib, the effect of dexamethasone (DEX) and the phosphodiesterase-4 (PDE-4) inhibitor 
rolipram on spheroid formation.
Results
After MCF-7 human breast adenocarcinoma cells had been cultured on the RPM for 24 h, we detected two differ-
ent phenotypes: Cells growing adherently within a 2D monolayer (AD) and cells growing in form of 3D aggregates 
exhibiting no glandular structures after this short-term exposure. The MCS had various sizes (max. 300 µm) and 
were floating in the supernatant (Fig. 1B). In the corresponding controls incubated under normal 1g-conditions 
only cells growing in 2D monolayers could be seen (Fig. 1A). The cells growing three-dimensionally in form of 
MCS were viable. This was demonstrated by testing the adhesion of the MCS (Fig. 1C) on slide flasks and by the 
migration behavior of the cells clearly seen at 4 h of incubation (Fig. 1D). After 24 h a large number of cells are 
migrating out of the MCS (Fig. 1E). In addition, acridine orange/ethidium bromide staining showed that MCS 
cells were viable and impermeable to the dye (Fig. 1G; green fluorescence) like the RPM AD cells (Fig. 1G; insert) 
and the 1g-control MCF-7 cells (Fig. 1F). In case of dead or necrotic cells, the cells would have taken up the dye 
and shown a red fluorescence. This is demonstrated in the insert of Fig. 1F, where red cells are visible when stained 
living cells are kept without medium under the microscope for another 5 min and photographed afterwards.
Effect of RPM-exposure on NFκB. In order to see, whether the NFκB-p65 location and content of MCF-7 
cells is like that of FTC-133 follicular thyroid cancer cells14 involved in the cellular processes taking place during 
the first 24 h of RPM-exposure, we performed a NFκB-p65 immunofluorescence staining and Western blot analy-
ses. The antibodies used are listed in Table 1. The Fig. 1H and I reveal MCF-7 cells stained for NFκB-p65. It can be 
seen that NFκB-p65 is equally distributed in the cytoplasm of cells cultured under static 1g-conditions (Fig. 1H). 
After a 24-hour RPM-exposure NFκB-p65 protein appeared in the nucleus of MCS cells (Fig. 1I; upper insert). 
Fluorescence brightness shown in the upper and lower inserts of Fig. 1I suggested more NFκB-p65 in the nucleus 
and cytoplasm of MCS cells than in the cytoplasm of adherent cells exposed to the RPM.
NFκB proteins comprise different variants including NFκB-p50, -p52 and -p65. They are encoded by the gene 
loci NFKB1, 2 and 3. The various proteins form dimeric transcription factors that regulate the expression of genes 
influencing a broad range of biological processes20–22. NFκB proteins are bound and inhibited by IκB proteins. 
Both, effectors and inhibitors may be activated by external signals, which trigger expression, phosphorylation and 
dimerization of various components as well as their translocation from the cytoplasm to nucleus, where it binds 
to specific DNA sequences (response elements). In order to investigate whether the differences in localization and 
amount of NFκB-p65 observed in Fig. 1H and I are only due to a re-distribution or are also due to a new synthesis 
of NFκB-p65 proteins, we performed qPCR of the NFKB1, NFKB2, NFKB3, NFKBIA, NFKBIB, NFKBIE and 
NFKBG genes (Fig. 2). Figure 2D,F,L indicate a tendency of a non-significant upregulation of NFKB2, NFKB3, 
NFKBIB genes under simulated microgravity (s-µg) in AD cells and especially in MCS, while Fig. 2A,I,M,N show 
a significant upregulation of NFKB1, NFKBIA, NFKBIE and NFKBG genes in MCS cells as compared to control 
cells. In AD cells only the IKBKG gene is significantly enhanced in comparison to the control cells. In general, the 
Western blot analyses performed on the same group as the qPCR, point in a similar direction as the correspond-
ing gene expression pattern along with the corresponding un-phosphorylated proteins (Fig. 2B,G,J). Interestingly, 
the phosphorylated (p−) variants of the proteins are enhanced mainly in RPM-exposed cells (Fig. 2C,E,H). 
Hence, a significant phosphorylation of NFκB proteins during MCS formation on the RPM may be considered.
Genes of factors known to be involved in spheroid formation. Because the growth behavior, NFKB3 
gene expression and NFκB p65 protein accumulation were similar in FTC-133 and MCF-7 cells, we investigated 
the expression of other genes, which are assumed to play a role in the formation of 3D aggregates of human can-
cer cells14,23. The primers used are listed in Table 2. The gene expression status was studied after 24 h by qPCR 
in 1g-control cells, AD and MCS cells comparatively. These qPCR experiments revealed: The gene expression of 
annexin A1 (ANXA1) and annexin A2 (ANXA2) were significantly upregulated in MCS compared to 1g-control 
cells, while their expression was unregulated in AD samples (Fig. 3A,B). In addition, caveolin-2 (CAV2) and 
intercellular adhesion molecule 1 (ICAM1) mRNAs were both elevated in MCS. The expression was significantly 
upregulated in MCS compared to the corresponding 1g-controls (Fig. 3C,H). In contrast to CAV2, the connec-
tive tissue growth factor (CTGF) gene expression was significantly upregulated in AD as well as in MCS samples 
(Fig. 3D).
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Figure 1. (A–E) Phase contrast microscopy: (A) Native MCF-7 cells cultured for 24 h under 1g-conditions. (B) 
RPM-exposed sample showing two phenotypes (adherently growing MCF-7 cells and MCS). A representative 
example of a MCS is indicated by the white arrowhead. (C) Adhesion of MCS to the bottom of a slide flask 
after 2 h. (D) Migration of MCF-7 cells out of the MCS after 4 h and (E) Migration of MCF-7 cells out of the 
MCS after 24 h. (F–I) Confocal laser scanning microscopy: (F,G) Acridine orange/ethidium bromide staining 
revealed a green fluorescence in all cells after 24 h which indicates viability. (F) 1g-conditions (insert: positive 
control (PC) of acridine orange/ethidium bromide assay after approximately 5 min incubation). (G) viable 
cells in the MCS (insert: viable RPM-AD cells). (H) NFκB immunofluorescence staining of 1g-control cells: 
NFκB is predominantly detectable in the cytoplasm and I: RPM-exposed samples: nuclear (white arrows) and 
cytoplasmatic NFκB in the MCS. Upper insert: magnification of indicated area. Lower insert: NFκB detection 
in RPM AD cells, same magnification as in I. Nuclei are counterstained with DAPI. Scale bars in (A–E) 100 µm; 
scale bars in (F,G) 10 µm; scale bars in (H and I): 20 µm. 5 samples of each condition were examined separately.
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Both, tissue inhibitor of metalloproteinases 1 (TIMP1) and plasminogen activator inhibitor 1 (PAI1) mRNAs 
were not significantly regulated, however, a tendency of an upregulation in AD and MCS was visible (Fig. 3E,F). 
Both factors inhibit metalloproteinases including metalloproteinase 9 (MMP9), whose mRNA was not signifi-
cantly regulated (Fig. 3G).
Additional genes involved in intrinsic and extrinsic pathways of programmed cell death, were selected, 
because apoptosis was found repeatedly to accompany cell response to removing gravity1,5,11,14. Casp3 and 
Casp9 mRNAs were not significantly changed in AD and MCS compared to their corresponding controls 
(Fig. 4B,D). However, only MCS versus control showed a significant upregulation of caspase-8 (Casp8) (Fig. 4C). 
Furthermore, the cellular tumor antigen p53 (p53) gene expression was significantly enhanced in MCS versus 
control cells (Fig. 4G). The cytochrome c1 (CYC1), poly(ADP-ribose)-polymerase 1 (PARP1) (Fig. 4H,I) and 
tumor necrosis factor receptor superfamily member (FAS) mRNAs (Fig. 4A) were upregulated in MCS samples 
compared to the control group. In addition, the apoptosis regulator Bcl-2 (BCL2) mRNA remained unregulated 
in AD and MCS cells (Fig. 4E). In contrast, the apoptosis regulator BAX (BAX) gene expression was significantly 
upregulated in AD and MCS samples compared to the control cells (Fig. 4F). However, many of them exhibited 
significant regulations in at least one of the three possible permutations of gene expression comparisons between 
our experimental groups.
Microarray analysis. In order to detect further genes, which change their expression activity, during 
the first 24 h of culturing MCF-7 cells on the RPM, we performed microarray analyses on 1g-control, AD and 
MCS cells (Fig. 5A). The microarray analysis (Table 3 and Supplemental Table 1) did not show a significant 
microgravity-dependent change in NFκB-p65 expression. Moreover, it revealed a rather stable mRNA expression 
pattern. In total 319 genes (331 probes, 330 probes annotated to 319 genes) transcripts were significantly differ-
entially expressed (5% false discovery rate (FDR) in Analysis of variance (ANOVA)). In the pairwise comparison 
of control cells, AD and MCS, the expression of 140 significantly differentially expressed genes and open reading 
frames was changed 1.4-fold (Supplemental Table 1). However, a two- or more-fold change of the mRNA was 
merely found in 23 genes (Table 3). As a two- or more-fold change is usually considered to indicate biological 
relevance, we studied these genes in more detail.
19 of the genes were downregulated more than two-fold and 4 genes were upregulated at least two-fold 
(Table 3). 10 of the down-regulated genes code for proteins linked to oxygen levels or hypoxia24–30. The degree 
of downregulation of the expression of these genes was very similar in AD and MCS cells. But myristoylated 
alanine-rich C-kinase substrate (MARCKS), which codes for an actin interacting protein, is more significantly 
(5% FDR ANOVA) downregulated in MCS than in AD cells31. A more profound difference between AD and MCS 
cells was seen, when the upregulated genes were analyzed, which code for the cytoskeletal protein gamma-enteric 
smooth muscle actin (ACTG) and additional three proteins suppressing apoptosis and regulating the concentra-
tion of heme, which influences apoptosis32–34. All 4 genes indicated were significantly upregulated (>2 fold) only 
in MCS cells (Table 3).
Because 10 of the 19 genes found significantly downregulated are related to oxygen homeostasis, we applied 
the Pathway Studio analysis to see whether there is an interaction between them (Figs 6 and 7). Interestingly, we 
did not see significant interactions of these factors, neither at protein nor at gene level. Interaction at gene and 
protein level was, however, detected, when all 23 factors shown in Table 3 were analyzed. A cross-linking goes 
through 7 of the 23 genes (Fig. 5B) which code for 3 extracellular, 1 membrane, 5 nuclear, 2 mitochondrial and 12 
cytosolic proteins (see also Fig. 7, Table 3). Hemoxygenase (HMOX1) is the most networked gene.
In order to examine, whether the genes determined by qPCR as upregulated in MCS cells interact with the 
differentially expressed genes detected in the gene array analysis, we subjected the experimental results to the 
Pathway studio analysis. The candidates comprised 41 items including RELA (NFKB3) and Hemox-1. They com-
pleted a complicated network consisting of 31 of the 41 factors at gene (Fig. 6) and protein levels (Fig. 7). Figures 5 
and 6 indicate that the genes recognized before to be important in spheroid formation and the genes noticed in 
gene array analysis very well fit into the networks (see also Table 3). HMOX1 and RELA show strong interaction at 
a genetic level (Fig. 6), but no mutual influence has so far been detected on the protein level (Fig. 7). In addition, 
the ICAM1 gene, which codes for a cell adhesion protein is under the positive influence of upregulated genes such 
as FAS, PARP1, P53, CTGF, and NFKB1, but may be suppressed by caspase-3. Besides of CTGF, these genes are 
significantly upregulated only in MCS cells.
Antibody Dilution Company Molecular weight Catalog Number
p-NFκB p50 1/1000 Thermo Fisher 50 kDa #710460
p-NFκB p52 1/1000 Thermo Fisher 110 kDa #PA5-17385
Anti-NFκB p105/p50 1/1000 Abcam 50, 100 kDa #ab32360
Anti-p-NFκB p65 1/1000 Abcam 70 kDa #ab86299
Anti-IκBα 1/1000 Cell-Signaling 39 kDa #9242
Anti-p-IκBα 1/1000 Cell-Signaling 40 kDa #2859
Anti-NFκBp65 1/1000 Cell-Signaling 65 kDa #C22B4
Anti-Cofilin 1/1000 Abcam 19 kDa #ab124979
Table 1. Antibodies applied for Western blot Analysis.
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Impact of targeting PARP and NFκB on spheroid formation. In order to evaluate the functional 
effects of PARP and NFκB, we performed inhibition assessments using the drugs olaparib, dexamethasone (DEX) 
and rolipram. Figure 8 shows the target proteins of the three drugs. According to a STITCH 4 database search 
Figure 2. (A) NFKB1 gene expression; (B) NFkBp50 Western blot analysis; (C) phosphorylated (p)-NFκBp50 
Western blot analysis; (D) NFKB2 gene expression; (E) p-NFκBp52 Western blot analysis; (F) NFKB3 gene 
expression; (G) NFκBp65 Western blot analysis; (H) p-NFkBp65 Western blot analysis; (I) NFKBIA gene 
expression; (J) IκBα Western blot analysis; (K) p- IκBβ Western blot analysis; (L) NFKBIB gene expression; (M) 
NFKBIE gene expression; (N) IKBKG gene expression. The position (arrow) and molecular size (in kD) of the 
investigated proteins are indicated on each of the Western blot membrane images. Cofilin 1 was used as loading 
control. The vertical lines indicate group separation giving n = 5 per group.
www.nature.com/scientificreports/
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(chemical-protein interaction networks; http://stitch.embl.de/), it can be assumed that DEX preferentially inhib-
its NROB1, NR3C1 and NR3C2 (Fig. 8, green bars), but has side effects cross-reacting with a couple of other 
factors including IL10 and CDK1 (Fig. 8). Similarly, olaparib inhibits PARP1 and PARP2 (Fig. 8, green bars) and 
has additional effects on other eight proteins (Fig. 8). Rolipram mainly blocks the action of PDE4A, PDE4B and 
PDE4D (Fig. 8, green bars). To some degree it also interacts with factors like IL6, IL10, APP, and FOS.
Factor Primer name Sequence 5′ - 3′
18 S
18S-F GGAGCCTGCGGCTTAATTT
18S-R CAACTAAGAACGGCCATGCA
Annexin A1; ANXA1
ANXA1-F GCCAAAGACATAACCTCAGACACAT
ANXA1-R GAATCAGCCAAGTCTTCATTCACA
Annexin A2; ANXA2
ANXA2-F GGTACAAGAGTTACAGCCCTTATGACA
ANXA2-R CATGGAGTCATACAGCCGATCA
Apoptosis Regulator BAX; BAX
BAX-F GTCAGCTGCCACTCGGAAA
BAX-R AGTAACATGGAGCTGCAGAGGAT
Apoptosis Regulator BCL-2; BCL2
BCL2-F TCAGAGACAGCCAGGAGAAATCA
BCL2-R CCTGTGGATGACTGAGTACCTGAA
Caspase 3; CASP3
Casp3-F CTCCAACATCGACTGTGAGAAGTT
Casp3-R GCGCCAGCTCCAGCAA
Caspase 8; CASP8
Casp8-F TGCAAAAGCACGGGAGAAAG
Casp8-R CTCTTCAAAGGTCGTGGTCAAAG
Caspase 9; CASP9
Casp9-F CTCCAACATCGACTGTGAGAAGTT
Casp9-R GCGCCAGCTCCAGCAA
Caveolin 2; CAV2
Cav2-F GATCCCCACCGGCTCAAC
Cav2-R CACCGGCTCTGCGATCA
Connective Tissue Growth Factor; CTGF
CTGF-F ACAAGGGCCTCTTCTGTGACTT
CTGF-R GGTACACCGTACCACCGAAGAT
Cytochrome C; CYC
Cyc-F CACTGCGGGAAGGTCTCTAC
Cyc-R GGGGTGCCATCGTCAAACTC
NF-kappa-B transcription complex P105/P50; NFKB1
NFkB1-F CTTAGGAGGGAGAGCCCAC
NFkB1-R TGAAACATTTGTTCAGGCCTTC
NF-kappa-B transcription complex P100/P52; NFKB2
NFkB2-F GTACAAAGATACGCGGACCC
NFkB2-R CCAGACCTGGGTTGTAGCA
NF-kappa-B transcription complex P65
NFkB-F CGCTTCTTCACACACTGGATTC
NFkB-R ACTGCCGGGATGGCTTCT
NF-kappa-B essential modulator (NEMO); IKBKG
IkBKG-F AACTGGGACTTTCTCGGAGC
IkBKG-R GGCAAGGGCTGTCAGCAG
NF-kappa-B inhibitor alpha; NFKBIA
NFkBIa-F AATGCTCAGGAGCCCTGTAAT
NFkBIa-R CTGTTGACATCAGCCCCACA
NF-kappa-B inhibitor beta; NFKBIB
NFkBIb-F CCCGGAGGACCTGGGTT
NFkBIb-R GCAGTGCCGTGTCCCC
NF-kappa-B inhibitor epsilon; NFKBIE
NFkBIe-F TGGGCATCTCATCCACTCTG
NFkBIe-R ACAAGGGATTCCTCAGTCAGGT
Tumor necrosis factor receptor superfamily member 6 (Fas); FAS
CD95-F AGTCTGGTTCATCCCCATTGAC
CD95-R AGGGATTGGAATTGAGGAAGACT
Intercellular adhesion molecule 1; ICAM1
ICAM1-F CGGCTGACGTGTGCAGTAAT
ICAM1-R CTTCTGAGACCTCTGGCTTCGT
Matrix metalloproteinase-9; MMP9
MMP9-F CCTGGAGACCTGAGAACCAATC
MMP9-R TTCGACTCTCCACGCATCTCT
Cellular tumor antigen p53; p53
p53-F CCTGGATTGGCCAGACTGC
p53-R TTTTCAGGAAGTAGTTTCCATAGGT
Plasminogen activator inhibitor 1; PAI1
PAI1-F AGGCTGACTTCACGAGTCTTTCA
PAI1-R CACTCTCGTTCACCTCGATCTTC
Poly [ADP-ribose] polymerase 1; PARP1
PARP1-F CGAGTCGAGTACGCCAAGAG
PARP1-R CATCAAACATGGGCGACTGC
Metalloproteinase inhibitor 1; TIMP1
TIMP1-F GCCATCGCCGCAGATC
TIMP1-R GCTATCAGCCACAGCAACAACA
Table 2. Primers used for quantitative real-time PCR All sequences are given in the 5′–3′ direction.
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To determine the formation of spheroids when molecules of interest are inhibited, we treated the MCF-7 cells 
with various concentrations of olaparib (0 M, 2.5 µM, 5 µM and 10 µM), DEX (0 M, 0.01 µM, 0,1 µM, 1 µM) and 
rolipram (0 M, 1 µM, 10 µM), while exposed to the RPM for 24 h. To exclude toxic effects of the used solvent and/
or the drugs on the MCF-7 cells, we prepared 24 h static 1g-experiments with solvent and the mentioned drug 
concentrations (Supplemental Fig. 1). After a 24 hour-exposure, the cells were stained with acridine orange/
ethidium bromide to examine the cell viability (Supplemental Fig. 1). None of the used concentrations of solvent 
and drugs had a cytotoxic effect on the cells, as presented by the green staining, while no red staining of the nuclei 
was detectable (Supplemental Fig. 1). In addition, no increased cell detachment or formation of cell aggregates 
was noticed due to drug or solvent supplementation.
We exposed the MCF-7 cells to the RPM for 24 h including the drug concentrations mentioned. While treat-
ment with olaparib and rolipram did not show visible effects on the formation of early spheroids (Fig. 9A–F,M–P), 
the number of visible MCSs seemed to decrease with increasing concentration of DEX (Fig. 9G–L). Acridine 
orange/ethidium bromide staining revealed viable cells in RPM-AD cells as well as in MCS (Supplemental 
Fig. 1N, arrow indicates a MCS).
Discussion
Organisms live on Earth under the permanent influence of gravity. Removing this influence results in remode-
ling of various tissues in humans. For example bone loss and muscle atrophy can be observed in astronauts and 
cosmonauts after long-term spaceflights35. In addition, various changes in different types of human cells were 
detected. Examples are macrophages producing less reactive oxygen in microgravity compared to 1 g36 and human 
thyroid cancer cells which form 3D cell aggregates, when cultured for a longer time in microgravity2. This makes 
microgravity a valuable environment for studies on a number of cellular characteristics not understood so far37. 
However, long-term removal of gravity achieved by spaceflights is very expensive and seldom performed. With 
the help of ground-based facilities, which were constructed, to simulate microgravity on Earth, some aspects of 
annulling gravity can be studied. Such devices, including the RPM, trigger at least a part of the incubated cells to 
detach from the bottom of a culture flask and to form 3D aggregates like they are observed after spaceflights1,2. 
Even though the RPM produces sheer forces, which are nearly completely absent in real microgravity38,39, it is 
generally accepted that the cause of spheroid formation of cells cultured either on a RPM or in space is the 
absence of cell sedimentation in both conditions1,2,40, as no other cause could be identified until today.
Also MCF-7 cells form spheroids when exposed to the RPM10. In contrast to thyroid cancer cells, which only 
form spheres, the MCF-7 cells form 3D structures that have central holes after a five-day RPM-exposure, which 
Figure 3. Expression of genes putatively involved in MCS-formation. (A) Annexin A1 (ANXA1), (B) Annexin 
A2 (ANXA2), (C) Caveolin-2 (Cav2), (D) Connective tissue growth factor (CTGF), (E) Metalloproteinase 
inhibitor 1 (TIMP1), (F) Plasminogen activator inhibitor 1 (PAI1), (G) Matrix metalloproteinase 9 (MMP9), 
(H) Intercellular adhesion molecule 1 (ICAM1), were analysed after 24 h of RPM-exposure. All values are given 
as mean ± standard deviation. *p < 0.05 vs. corresponding 1g-control. AD: adherent cells, MCS: multicellular 
spheroids, after RPM-exposure. Number of replicates is 4.
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remind of duct structures of normal epithelial breast cells10. After a 24 h RPM-exposure dense MCS of MCF-7 
cells similar to FTC-133 thyroid cancer spheroids or MCS from normal thyroid cells were visible14,41.
The MCF-7 breast cancer cell line is characterized as estrogen-receptor (ER)-positive, and progesterone 
receptor (PR)-positive. It belongs to the luminal A molecular subtype42. MCF-7 cells show characteristics of 
differentiated breast epithelium and are positive for epithelial markers and negative for mesenchymal mark-
ers like vimentin42. MCF-7 cells have demonstrated the ability to form MCS under static 1g-conditions using 
non-adherent Petri dishes43. These MCS can mature after long-term culture to lumen-containing spheroids43.
Normal cells such as endothelial blood vessel cells for example form tubular structures when cultured on a 
RPM5. Human chondrocytes form cartilage pieces when cultured in space and on the Rotating Wall Vessel44 or 
when they were exposed to the RPM45.
These observations point to the possibility that the technique of microgravity-dependent spheroid formation 
could be exploited for tissue engineering purposes in the future46, perhaps also in breast reconstruction after 
surgery. In this study, we investigated the early phase of spheroid formation of MCF-7 cells exposed to simulated 
microgravity created by a RPM.
MCF-7 cells of a parent population, which grow either as MCS cells or as a monolayer showed similar and 
different features after a 24 hour-exposure to the RPM. Both states of cellular appearance exhibited an increased 
expression of CTGF and BAX and a rather similarly decreased expression of adrenomedullin (ADM), aldolase 
(ALDOC), angiopoietin-like 4 (ANGPTL4), ankyrin repeat domain 37 (ANKRD37), BCL2 interacting protein 
3 (BNIP3), N-myc downstream regulated 1 (NDRG1), whose products are affected by oxygen levels24–30. The 
Figure 4. Gene expression of genes whose products are associated with apoptosis pathway. (A) Fas, (B) 
Caspase-3 (Casp3), (C) Caspase-8 (Casp8), (D) Caspase-9 (Casp9), (E) Apoptosis regulator Bcl-2 (BCL2), 
(F) Apoptosis regulator BAX (BAX), (G) Cellular tumor antigen p53 (p53), (H) Cytochrome C 1 (Cyc1), (I) 
Poly ADP-ribose polymerase (PARP1) were analyzed after 24 h of RPM-exposure. All values are given as 
mean ± standard deviation. *p < 0.05 vs. corresponding 1g-control. AD: adherent cells, MCS: multicellular 
spheroids, after RPM-exposure. Number of replicates is 4.
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decrease of ADM, ALDOC, ANGPTL4, ANKRD37, BNIP3, NDRG1 may be explained by an increase in oxygen 
concentration within vented culture flasks observed after 24 h of incubation on the RPM47. Such an increase may 
be the reason for the down-regulation of various genes whose products were changed in response to oxygen levels 
and regulate glycolysis, as the regulation was very similar in adherent and in MCS cells (Supplemental Table 1). In 
addition, spheroid formation is observed in closed and not-vented incubation chambers during a spaceflight and 
during clinorotation (clinostat device), which is another method of preventing cell sedimentation on ground2,40. 
This indicates that different oxygen concentrations are not accountable for spheroid formation. Therefore, an 
enhanced oxygen concentration together with the down-regulation of hypoxia-inducible factor (HIF)-related 
genes may be an epiphenomenon, when cells are incubated on the RPM in vented culture flasks. As oxygen 
enhancement cannot be considered to trigger the switch from a 2D to a 3D growth behavior, we focused on genes 
which have been differently regulated in AD and MCS cells during the early 24 h of incubation.
Differences in gene expression changes were observed in genes of factors playing a role in apoptosis. These 
genes were clearly elevated in MCS than in AD samples. They comprise p53, CYC1, PARP1, FAS, Casp8 as well as 
ANXA148–50. These elevated apoptotic factors in MCS are accompanied by factors promoting cell survival. One 
of these genes is sphingosine-1-phosphate receptor 3 (S1PR3), the other one is heme oxygenase-1. They are both 
up-regulated in MCS as detected by microarray and code for proteins favoring cell survival33,34.
HMOX-1 codes for an enzyme, degrading heme and exhibits together with its degradation products, cyto-
protective properties33. This enzyme may be localized in various cellular compartments. In caveolae HMOX-1 
is inhibited by caveolin-151. In thyroid cells an increased concentration of caveolin-1 prevents spheroid forma-
tion52,53. Therefore, it may not be excluded that HMOX-1 plays a role in spheroid formation.
According to the literature, both HMOX-1 and NFκB p65 were mutually downregulating their gene expres-
sions54,55. In our experimental setting on breast cancer cells grown on the RPM, HMOX-1 was upregulated, 
while NFKB3 remained unregulated. The HMOX-1 upregulation could be due to a positive influence of ADM 
and PARP-156,57. Despite the NFKB3 gene expression remained unchanged (Fig. 2F), NFκB p65 protein was 
Figure 5. (A) K-mean clustering of significant expression differences in the microarray experiment (5% 
FDR, N = 331 probes). Using k = 4 the first cluster comprises 103 probes downregulated in MCS and AD. The 
second and forth cluster comprise 66 and 63 probes upregulated in MCS. Cluster 2 genes have an intermediate 
expression in AD. The 99 probes in cluster three are downregulated in MCS. (B) Pathway studio analysis of 
genes detected by the gene array analysis: The arrows indicate interaction. HMOX1 is most net-worked.
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accumulated in MCS (Fig. 2G) and enriched within the nucleus. This fact points to an enhanced NFκB p65 trans-
location activity regulated by NFκBIA and NFκBIB (Figs 6 and 7)18,58. Becker-Weimann et al.19 found that NFκB 
is a key regulator in the formation of organized spheres in breast cancer cells cultured in 3D matrigels. While 
organized spheres had a low expression of NFκB p65, unorganized spheres presented an upregulation19. This is 
Gene symbol Fold change AD vs. controls Fold change MCS vs. controls Oxygen
ADM −3.97341 −3.71790 sensitive
ALDOC −2.72112 −2.93859 sensitive
ANGPTL4 −2.82266 −2.52424 sensitive
ANKRD37 −3.30216 −3.47036 sensitive
BHLHE40 −2.63050 −2.12209
BNIP3 −2.06507 −1.99325 sensitive
BNIP3L −2.10573 −2.65328 sensitive
C15ORF48 −1.28973 −2.14925
DDIT4 −2.36264 −2.80513 sensitive
FOS −2.23903 −1.62010
MARCKS −1.23023 −2.21407
MT1X −2.30906 −2.49814
NDRG1 −2.95903 −2.78486 sensitive
PFKFB3 −2.10202 −3.13231 sensitive
PFKFB4 −3.20572 −2.84829 sensitive
PGM1 −1.77618 −2.05219
PLA2G10 −1.17541 −2.21319
PPP1R3C −1.72085 −2.07604
TMED10 −1.13444 −2.60338
SLC48A1 1.31299 2.07465
S1PR3 1.46902 2.07908
ACTG2 1.67742 2.17152
HMOX1 1.23716 2.78409
Table 3. Genes changed two- or more-fold after a 24 h-RPM-exposure.
Figure 6. Pathway studio analysis of genes analyzed in the study by the gene array analysis and qPCR. Arrows 
indicate influence. Rims around the icon indicate up- (red) and down-regulation (blue). Green means un-
regulated. The lower half of a rim indicates regulation in MCS, the upper half indicates regulation in the AD 
cells.
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in concert with our findings that NFκB p65 is enhanced in 24 h adherent and MCS cells as these early spheroids 
showed a random accumulation of cells (Fig. 1). The random accumulation of MCF7 cells was organized in glan-
dular structures with polarized cells after 5 days of cultivation on the RPM10. A deeper investigation of the corre-
lation between cell polarization and NFκB in RPM exposed cells will surely shed further light on the process of 
Figure 7. Pathway studio analysis of proteins whose genes were analysed in the study by the gene array analysis 
and qPCR. Arrows indicate interaction. Mitochondria (yellow), cell membrane (red) and nucleus (blue) are 
indicated to support localization of the various proteins.
Figure 8. Pharmacological studies. STITCH 4 search for targets of olaparib (A), dexamethasone (B) and 
rolipram (C). Primary targets are indicated by a green bar between the drug and the protein. Factors affected to 
a minor degree are shown by grey lines86.
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spheroid formation under microgravity. Furthermore, NFκB p65 translocation triggers the expression of various 
proteins including ICAM1, which in our experiments was upregulated in MCS (Fig. 3H). Hence, NFκB seems 
to play a central role in spheroid formation, which suggests that manipulation of NFκB activity by biological or 
pharmacological agents could influence spheroid formation or related processes59. The effect of NFκB p65 is 
directed towards ICAM1 also by PARP160. CTGF, via mitogen-activated protein kinase and NFκB activation, can 
induce proinflammatory genes in murine tubuloepithelial cells61. Interestingly, the S1PR3 gene was upregulated in 
the MCS samples (Table 3). A recent paper demonstrated that sphingosine-1-phosphate increases the expansion 
of cancer stem cells via S1PR3 by a ligand-independent Notch activation in breast cancer62.
It is known that high levels of PARP-1 were associated with a poor prognosis in early breast cancer. PARP1 
overexpression was detectable in various cancer cell lines and was associated with malignant progression63. We 
found a high PARP1 expression in the spheroids and targeted it by PARP inhibition. Thus, we investigated the 
impact of olaparib (a competitive PARP-1/2 inhibitor) on the growth of MCF-7 breast cancer cells exposed to the 
RPM and to 1g-conditions (Fig. 9). MCF-7 cells had been already treated with olaparib in earlier studies and three 
different doses were tested (2.5, 5 and 10 µM)64. Recent data suggested that PARP inhibitors might be useful to 
treat estrogen receptor-positive and estrogen-dependent tumors65. Here we could show that targeting PARP1/2 
with olaparib did not alter the 3D aggregation of the MCF-7 cells cultured on the RPM, which indicated that 
PARP seems not to be the main key factor responsible for 3D spheroids formation in simulated microgravity.
In a second step, we used DEX to modulate the NFκB activity. It has been shown that the application of DEX 
promoted the NFκB transcriptional activity in MCF-7 cells66. Khan et al. identified that NFκB was also regulated 
by glucocorticoids and their receptor in MCF-7 breast cancer cells66. Here, we applied DEX to evaluate its impact 
on spheroid formation. After a 24-hour RPM-exposure we detected that 1 µM might inhibit the spheroid forma-
tion. This finding supports the hypothesis that NFκB might be involved in spheroid formation on the RPM. It is 
known that DEX suppresses the IL8 gene expression in airway epithelial cells67. We had shown earlier that the 
application of IL-8 protein facilitated the formation of MCS in thyroid cancer cell lines using the liquid-overlay 
technique68. Therefore, DEX might interact with IL8 to reduce MCS formation in this study, which has to be 
confirmed in the future.
Figure 9. Phase contrast microscopy of drug-treated cells exposed to the RPM. Olaparib-treated cells static 
control: (A) 2.5 µM, (C) 5 µM, (E) 10 µM. Olaparib-treated cells exposed to the RPM for 24 h: (B) 2.5 µM, 
(D) 5 µM, (F) 10 µM. DEX-treated cells static control: (G) 0.01 µM, (I) 0.1 µM, (K) 1 µM. DEX-treated cells 
exposed to the RPM for 24 h: (H) 0.01 µM, (J) 0.1 µM, (L) 1 µM. Rolipram-treated cells static control: M) 1 µM, 
(O) 10 µM. Rolipram-treated cells exposed to the RPM for 24 h: (N) 1 µM, (P) 10 µM. The pyramid indicates 
increasing drug concentration. Scale bar: 100 µm.
www.nature.com/scientificreports/
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In addition, we tested a second agent known to target NF-κB. Rolipram is a cyclic adenosine monophosphate 
(cAMP)-specific phosphodiesterase (PDE-4) inhibitor and earlier used to influence MCF-7 cancer cells69. The 
agent has shown to prevent the NFκB binding activity in human chorionic cells70. In this experimental setting, 
we can report that the drug is not influencing 3D spheroid formation in the first 24 h of RPM-exposure (Fig. 9).
Future studies are necessary to clarify the exact mechanisms involved in the process of 3D aggregation and 
spheroid formation, such as genetic knockouts or knockins in cell lines71.
In addition, the genes CTGF, FAS and P53, which were upregulated in MCS and their products, have positive 
influence on the gene expression of ICAM172,73. ICAM1 is a surface protein, mainly detectable in endothelial 
cells, but also expressed in human breast cancer cells74. It may contribute to the cell-cell interaction required for 
spheroid formation either by direct binding to integrin beta 275 or by changing the structure of the cell adhesion 
complex as it was observed recently on normal thyroid cells17. Interestingly, during earlier studies on MCF-7 cells, 
we detected a downregulation of ICAM1 in AD and MCS cells after a 24-hour-exposure to the RPM10. The reason 
might be either due to the changed serum supplementation, as growth factor concentration is unpredictable76, or 
due to the random walk of the RPM which incorporates different variances of stress39. In both cases the onset of 
apoptosis may vary, which reduces ICAM1 expression via caspase-311,77.
Taken together, our experiments suggest that NFκB family members and HMOX-1 interact on a gene level, 
when breast cancer cells transit from a 2D to a 3D growth on the RPM. They are changed in the same direction, 
when adherent and MCS-cells are compared (Fig. 6). Whether these alterations are accidental parallel events or 
mutually caused remains to be determined. Whether the up-regulated ANXA2 or the down-regulated MARCKS 
genes which both code for cytoskeleton interacting proteins or the genes of CAV2, TIMP1, PAI1 and MMP-9, 
which either code for membrane proteins or for enzymes regulating the extracellular matrix constitution, con-
tribute to this process remains to be determined in future studies. Interestingly, CAV2, TIMP1, and PAI1 show an 
up-regulation in these experiments, but have exhibited together with MMP9 a downregulation in earlier experi-
ments on thyroid cells9.
In addition, our studies deliver new knowledge about how these cells might behave in real micrograv-
ity. This data can be used to prepare future spaceflight missions. Hence, using these and earlier results as a 
basis10,78,79, we plan to conduct a future NASA and DLR space experiment like the successfully flown Cellbox-1 
(NanoRacks-CellBox-Thyroid Cancer: http://www.nasa.gov/mission_pages/station/research/experiments/1648.
html 52,53) onboard the International Space Station in order to increase the current knowledge of the behavior of 
human breast cancer cells under real microgravity in space with a special focus on early cytoskeletal changes and 
3D growth.
Methods
Cell culture. MCF-7 human breast adenocarcinoma cells (Fig. 1A) were purchased from the American type 
culture collection (ATCC) (Manassas, VA, USA). Cells were cultivated in RPMI 1640 medium (Life Technologies, 
Naerum, Denmark) supplemented with 10% fetal calf serum (FCS) (Biochrom, Berlin, Germany) and 1% penicil-
lin/streptomycin (Biochrom) at 37 °C and 5% CO2. One day prior to the experimental run on the RPM, cells were 
seeded either in slide flasks (Thermo Fisher Scientific, Roskilde, Denmark) (3 × 105 cells/cm²) for fluorescence 
staining or in T25 (1 × 106 cells) vented cell culture flasks (Sarstedt, Nümbrecht, Germany) for RNA and protein 
extraction. Before starting the run, flasks were filled up with medium, taking care that no air bubbles remain. A 
detailed procedure has been published previously9,23. To test the viability of the cells in the multicellular sphe-
roids (MCS), the MCS were collected after 24 h (Fig. 1B) and seeded in slide flasks. The adhesion and migration 
behavior of the cells of the MCS was examined by phase contrast microscopy after 2 h, 4 h and 24 h (Fig. 1C–E).
Drug treatment. For targeting molecules of interest, we seeded 106 MCF-7 cells in slideflasks. After 24 h 
the cells were synchronized for 4 h and afterwards treated with the respective chemical agents for 24 h during 
RPM-exposure or without RPM-exposure. To target PARP we used the PARP 1/2 inhibitor olaparib (Selleckchem, 
Absource Diagnostics, Munich, Germany). We prepared a stock solution in DMSO. The aliquots were stored at 
−80 °C until use. Concentrations of 2.5, 5, or 10 µM olaparib in medium were applied64. Negative controls were 
incubated with DMSO only.
For targeting NFκB we applied dexamethasone (DEX) (Sigma-Aldrich, Taufkirchen, Germany). According to 
Bruxant et al.80 and Khan et al.66 we treated the MCF-7 cells with DEX (0 M, 0,001 µM, 0,1 µM, 1 µM). The MCF-7 
cells were treated with DEX dissolved in water for 24 h.
Moreover, we applied the PDE4 inhibitor rolipram. We used the following doses 0 M, 1 µM, and 10 µM69. 
Rolipram was first prepared as a stock solution in ethanol. Control MCF-7 cells were treated with an equivalent 
volume of the solvent.
Random Positioning Machine. The desktop RPM (Airbus Defense and Space (ADS), Leiden, The 
Netherlands) was located in a standard incubator with 37 °C and 5% CO2. The RPM was operated in real random 
mode with random direction and interval and a maximum speed of 12.5 revolutions per minute. Sample flasks to 
be tested were placed onto the middle frame with a maximal distance of 7 cm to the center of rotation allowing a 
µg quality between 10−4 and 10−2 g, which is reached over time40,81. Corresponding static 1g-controls, which were 
completely filled with medium, were placed next to the RPM in the same incubator (n = 15 samples each group/
run).
Phase contrast microscopy. Cells were observed and photographed using an Axiovert 25 Microscope 
(Carl Zeiss Microscopy, LLC, USA) and a Canon EOS 550D camera (Canon GmbH, Krefeld, Germany)23.
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Sample collection. After 24 h the cells were investigated and photographed. The MCS were collected by mild 
centrifugation at 3000 g for 5 min and 4 °C and stored in liquid nitrogen. Harvesting of the adherent cells was per-
formed, by using a cell scraper after carefully adding ice-cold phosphate buffered saline (PBS, Life Technologies). 
The suspension was collected and centrifuged at 3000 g for 5 min and 4 °C followed by discarding the PBS and 
storage of the pellet in liquid nitrogen.
Acridine orange/ethidium bromide staining. Control and RPM-exposed MCF-7 cells of both pheno-
types MCS and adherently growing cells were stained with acridine orange/ethidium bromide (Molecular Probes, 
Darmstadt, Germany) as performed in previous studies82. The stained MCF-7 cells were immediately investigated 
by using a Zeiss LSM 710 confocal laser scanning microscope (Zeiss, Jena, Germany) as previously described9.
Indirect immunofluorescence staining of NFκB. Immunofluorescence analysis of NFκB p65 was per-
formed on 80% confluent MCF-7 cells after a 24 hour exposure to the RPM. The cells were fixed with 4% para-
formaldehyde for 25 minutes at room temperature (RT), permeabilized with 0.25% Triton™ X-100 for 10 minutes, 
and blocked with 5% BSA for 1 h at RT. Afterwards, the cells were labelled with NFκB [p65] rabbit polyclonal 
antibody (Thermo Fisher Scientific) at 2 µg/mL in 1% BSA and incubated overnight at 4 °C, then labelled with 
Alexa Fluor 488 goat anti-rabbit IgG secondary antibody (Thermo Fisher Scientific) at a dilution of 1:400 for 1 h 
at RT and washed 3 times. For nuclear staining, we used DAPI (4′,6-diamidin-2-phenylindol) (Sigma-Aldrich, 
Taufkirchen, Germany) for 5 min and washed the cells twice with DPBS. For evaluation, the slides were mounted 
with Fluoroshield (Sigma-Aldrich, Taufkirchen, Germany) and analysed with a Zeiss LSM 710 confocal laser 
scanning microscope9.
Western Blot Analysis. Western blot analysis was performed as recently published17. The RPM experiment 
for the Western blot analyses was performed three times. In each of these experiments five different culture 
flasks were mounted on the RPM. In parallel five 1g-control flasks were cultured next to the RPM. At the end 
of the experiment cells were harvested and an aliquot from each flask was subjected to Western blot analysis. In 
RPM-samples we detected two phenotypes (RPM-AD cells and RPM-MCS). Hence, the Western blot contains 
ten lanes loaded with RPM samples (AD and MCS), and five lanes loaded with 1g-control samples. The Western 
blot experiment was repeated thrice. The concentration was adjusted to a total protein load of 30 µg per well in 
Laemmli buffer. Criterion XT 4–12% precast gels (Biorad, Hercules, USA) were loaded and run for 1 h at 150 
volts. Transfer to a PVDF membrane was performed at 100 volts and 30 minutes. Membranes were blocked in 
0.3% I-Block (Applied Biosystems, Foster City, USA) in TBS-T overnight. The antibodies listed in Table 1 were 
applied for 2 h at room temperature followed by washing steps. The applied secondary antibody, a Horseradish 
peroxidase (HRP)-linked antibody was utilized at a dilution of 1:4000 (Cell Signaling Technology, Inc., Danvers, 
MA, USA) for additional 2 h at room temperature. Membranes were developed using Biorad Clarity Western 
ECL and imaged with an Image Quant LAS 4000 mini (GE Healthcare Life Science, Freiburg, Germany). Cofilin 
(CFL1) [EPR6375] (ABCAM, Cambridge, UK) was used as a loading control. The membranes were analyzed 
using ImageJ software (U.S. National Institutes of Health, Bethesda, MD, USA; http://rsb.info.nih.gov/ij/) for 
densitometric quantification of the bands83.
RNA and protein extraction. The RNA and protein extraction were performed using the AllPrep RNA/
Protein kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer’s protocol. The concentrations were 
determined with the spectrophotometer Ultrospec 2100 pro (Amersham Biosciences, Amersham, Great Britain).
Quantitative real-time PCR. Complementary DNA was produced using the First Strand cDNA Synthesis 
Kit (Thermo Fisher Scientific) following manufacturer’s instructions. qrtPCR was performed using the SYBR® 
Select Master Mix (Applied Biosystems, Darmstadt, Germany) and the 7500 Real-Time PCR System (Applied 
Biosystems) to determine the expression levels of target genes, shown in Table 2. Selective primers were designed 
to span exon-exon boundaries and to have a Tm of 60 °C using Primer Express software (Applied Biosystems), 
and were synthesized by TIB Molbiol (Berlin, Germany). Samples were measured in triplicate and were nor-
malized to the housekeeper 18 S rRNA. Comparative threshold cycle (ΔΔCT) methods were used for relative 
quantification of transcription levels, with 1 g set as 100%84.
Microarray technique. The 25 Illumina HumanWG-6_V2_0_R3 arrays have been normalized using the 
BeadStudio Gene Expression Module v3.3.7, and quantile normalization without background correction. After 
quantile normalization and exclusion of low or not expressed genes (minimum Illumina detection p-value > 0.05) 
a parametric ANOVA comparing the conditions control, AD and MCS was performed. Probes which undergo 
5% FDR85 were selected as differential expressed. Differentiation of the expression profiles was performed using 
hierarchical and k-mean clustering. The cluster analysis was done using Partek Genomic Suite 6.3 applying hier-
archical average linkage clustering and k-mean clustering with Euclidean distance function on standardized log2 
signal values. K was selected by analyses of the hierarchical clustering dendrograms.
Pathway analyses. To investigate mutual regulation of genes and to visualize localization and interactions 
between proteins, we entered relevant UniProtKB entry numbers in the Pathway Studio v.11 software (Elsevier 
Research Solutions, Amsterdam, The Netherlands). Graphs were generated for gene expression and protein regu-
lation and binding. The method was described previously9,52. STITCH 4 (Chemical-Protein Interaction Networks, 
European Molecular Biology Laboratory (EMBL), Heidelberg, Germany) was applied to investigate the interac-
tion of DEX, olaparib and rolipram with their targets. The data is given in Fig. 8.
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Statistical evaluation. Statistical evaluation was performed using SPSS 15.0 (SPSS, Inc., Chicago, IL, USA). 
The Mann-Whitney-U-Test was used to compare 1 g and s-μg conditions, as well as AD cells and MCS cells. All 
data is presented as mean ± standard deviation (SD) with a significance level of *p < 0.05.
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